1. Home
  2. BEDU vs CTSO Comparison

BEDU vs CTSO Comparison

Compare BEDU & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Scholar Education Holdings Limited each  representing four

BEDU

Bright Scholar Education Holdings Limited each representing four

N/A

Current Price

$2.19

Market Cap

65.0M

Sector

Real Estate

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.75

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEDU
CTSO
Founded
1994
1997
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.0M
45.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BEDU
CTSO
Price
$2.19
$0.75
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
5.5K
122.0K
Earning Date
01-23-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$224,321,752.00
$36,979,520.00
Revenue This Year
N/A
$9.51
Revenue Next Year
N/A
$24.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.89
52 Week Low
$1.35
$0.60
52 Week High
$2.28
$1.61

Technical Indicators

Market Signals
Indicator
BEDU
CTSO
Relative Strength Index (RSI) 56.64 49.37
Support Level $2.18 $0.70
Resistance Level $2.20 $0.75
Average True Range (ATR) 0.03 0.07
MACD -0.00 0.01
Stochastic Oscillator 35.71 59.60

Price Performance

Historical Comparison
BEDU
CTSO

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom and the United States. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: